Combining NMR and MS with Chemical Derivatization for Absolute Quantification with Reduced Matrix Effects.
暂无分享,去创建一个
Q. Fei | D. Raftery | G. A. Nagana Gowda | Haiwei Gu | P. Jasbi | Ping Zhang | Dongfang Wang | G. A. N. Gowda | Daniel Raftery | Qiang Fei | Ping Zhang | Paniz Jasbi
[1] C. Borchers,et al. Isotope-labeling derivatization with 3-nitrophenylhydrazine for LC/multiple-reaction monitoring-mass-spectrometry-based quantitation of carnitines in dried blood spots. , 2018, Analytica chimica acta.
[2] Guowang Xu,et al. Current and future perspectives of functional metabolomics in disease studies-A review. , 2018, Analytica chimica acta.
[3] Yie Hou Lee,et al. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases. , 2018, Mass spectrometry reviews.
[4] M. Jacob,et al. A targeted metabolomics approach for clinical diagnosis of inborn errors of metabolism. , 2018, Analytica chimica acta.
[5] G. Reid,et al. Metabolomics as a clinical testing method for the diagnosis of vaginal dysbiosis , 2018, American journal of reproductive immunology.
[6] Claudio Luchinat,et al. Metabolomics in breast cancer: A decade in review. , 2018, Cancer treatment reviews.
[7] D. Raftery,et al. NMR-Guided Mass Spectrometry for Absolute Quantitation of Human Blood Metabolites. , 2018, Analytical chemistry.
[8] Liang Li,et al. Overcoming Sample Matrix Effect in Quantitative Blood Metabolomics Using Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry. , 2017, Analytical chemistry.
[9] A. El-Aneed,et al. Mass spectrometric based approaches in urine metabolomics and biomarker discovery. , 2017, Mass spectrometry reviews.
[10] U. Sauer,et al. Frontiers of high-throughput metabolomics. , 2017, Current opinion in chemical biology.
[11] Robert Powers,et al. The future of NMR-based metabolomics. , 2017, Current opinion in biotechnology.
[12] D. Schoeller,et al. Dietary biomarker evaluation in a controlled feeding study in women from the Women's Health Initiative cohort. , 2017, The American journal of clinical nutrition.
[13] R. Eisenman,et al. Quantitative Method to Investigate the Balance between Metabolism and Proteome Biomass: Starting from Glycine. , 2016, Angewandte Chemie.
[14] O. Fiehn. Metabolomics by Gas Chromatography–Mass Spectrometry: Combined Targeted and Untargeted Profiling , 2016, Current protocols in molecular biology.
[15] D. Wishart. Emerging applications of metabolomics in drug discovery and precision medicine , 2016, Nature Reviews Drug Discovery.
[16] D. Raftery,et al. Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage. , 2015, Analytical chemistry.
[17] M. Stitt,et al. Synthesis and Use of Stable-Isotope-Labeled Internal Standards for Quantification of Phosphorylated Metabolites by LC-MS/MS. , 2015, Analytical chemistry.
[18] A. Terry,et al. Bio-generation of stable isotope-labeled internal standards for absolute and relative quantitation of phase II drug metabolites in plasma samples using LC–MS/MS , 2015, Analytical and Bioanalytical Chemistry.
[19] D. Raftery,et al. Massive glutamine cyclization to pyroglutamic acid in human serum discovered using NMR spectroscopy. , 2015, Analytical chemistry.
[20] J. Hurley,et al. Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis. , 2015, Cancer cell.
[21] Daniel Raftery,et al. Expanding the Limits of Human Blood Metabolite Quantitation Using NMR Spectroscopy , 2014, Analytical chemistry.
[22] B. Kumar,et al. Potential of metabolomics in preclinical and clinical drug development , 2014, Pharmacological reports : PR.
[23] Daniel Raftery,et al. Colorectal cancer detection using targeted serum metabolic profiling. , 2014, Journal of proteome research.
[24] John C Lindon,et al. The emergent role of metabolic phenotyping in dynamic patient stratification , 2014, Expert opinion on drug metabolism & toxicology.
[25] Daniel Raftery,et al. Quantitating Metabolites in Protein Precipitated Serum Using NMR Spectroscopy , 2014, Analytical chemistry.
[26] F. El-baz,et al. Study of plasma amino acid levels in children with autism: An Egyptian sample , 2014 .
[27] M. H. Angelis,et al. Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine , 2013, Journal of internal medicine.
[28] Daniel Raftery,et al. 15N-cholamine--a smart isotope tag for combining NMR- and MS-based metabolite profiling. , 2013, Analytical chemistry.
[29] R. Gerszten,et al. Toward new biomarkers of cardiometabolic diseases. , 2013, Cell metabolism.
[30] D. Wishart,et al. Translational biomarker discovery in clinical metabolomics: an introductory tutorial , 2012, Metabolomics.
[31] Ara W. Darzi,et al. Metabolic phenotyping in clinical and surgical environments , 2012, Nature.
[32] Daniel K Nomura,et al. Global profiling strategies for mapping dysregulated metabolic pathways in cancer. , 2012, Cell metabolism.
[33] D. Raftery,et al. Metabolic profiling: are we en route to better diagnostic tests for cancer? , 2012, Future oncology.
[34] John L. Markley,et al. Simultaneous Quantification and Identification of Individual Chemicals in Metabolite Mixtures by Two-Dimensional Extrapolated Time-Zero 1H−13C HSQC (HSQC0) , 2011, Journal of the American Chemical Society.
[35] F. Regnier,et al. In vitro stable isotope labeling for discovery of novel metabolites by liquid chromatography-mass spectrometry: Confirmation of gamma-tocopherol metabolism in human A549 cell. , 2010, Journal of chromatography. A.
[36] Mark R. Viant,et al. Environmental metabolomics: a critical review and future perspectives , 2009, Metabolomics.
[37] D. Raftery,et al. Metabolomics-based methods for early disease diagnostics , 2008, Expert review of molecular diagnostics.
[38] Daniel Raftery,et al. Class selection of amino acid metabolites in body fluids using chemical derivatization and their enhanced 13C NMR , 2007, Proceedings of the National Academy of Sciences.
[39] Sherry Wang,et al. Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. , 2007, Journal of pharmaceutical and biomedical analysis.
[40] H. Rosing,et al. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? , 2005, Rapid communications in mass spectrometry : RCM.
[41] J. C. Smith,et al. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. , 1997, Analytical chemistry.
[42] Daniel Raftery,et al. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics , 2007, Analytical and bioanalytical chemistry.